| Product NDC: | 58914-170 |
| Proprietary Name: | Carafate |
| Non Proprietary Name: | Sucralfate |
| Active Ingredient(s): | 1 g/10mL & nbsp; Sucralfate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 58914-170 |
| Labeler Name: | Aptalis Pharma Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019183 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19931216 |
| Package NDC: | 58914-170-14 |
| Package Description: | 414 mL in 1 BOTTLE (58914-170-14) |
| NDC Code | 58914-170-14 |
| Proprietary Name | Carafate |
| Package Description | 414 mL in 1 BOTTLE (58914-170-14) |
| Product NDC | 58914-170 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sucralfate |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 19931216 |
| Marketing Category Name | NDA |
| Labeler Name | Aptalis Pharma Inc. |
| Substance Name | SUCRALFATE |
| Strength Number | 1 |
| Strength Unit | g/10mL |
| Pharmaceutical Classes | Aluminum Complex [EPC],Organometallic Compounds [Chemical/Ingredient] |